Citadel Advisors »

Rapt Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.8M 394k 24.85
2023-09-30 $6.4M 384k 16.62
2023-06-30 $7.8M 415k 18.70
2023-03-31 $6.9M 374k 18.35
2022-12-31 $9.3M 470k 19.80
2022-06-30 $7.4M 408k 18.22
2022-03-31 $1.9M 85k 21.98
2021-12-31 $694k 19k 36.72
2021-09-30 $1.2M 40k 31.11
2021-06-30 $8.7M 274k 31.79
2021-03-31 $2.5M 111k 22.21
2020-12-31 $2.2M 112k 19.74